ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Cipher Pharmaceuticals Inc

Cipher Pharmaceuticals Inc (CPH)

14,53
-0,59
( -3,90% )
Aktualisiert: 16:42:19

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
14,53
Gebot
14,50
Fragen
14,55
Volumen
21.121
14,43 Tagesbereich 15,05
4,10 52-Wochen-Bereich 19,69
Marktkapitalisierung
Handelsende
15,12
Handelsbeginn
15,05
Letzte Trade
100
@
14.53
Letzter Handelszeitpunkt
16:42:19
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
71.234
Ausgegebene Aktien
23.988.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
17,03
Gewinn pro Aktie (EPS)
0,85
Erlöse
21,16M
Nettogewinn
20,38M

Über Cipher Pharmaceuticals Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Oakville, Ontario, Can
Gegründet
-
Cipher Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker CPH. The last closing price for Cipher Pharmaceuticals was $15,12. Over the last year, Cipher Pharmaceuticals shares have traded in a share price range of $ 4,10 to $ 19,69.

Cipher Pharmaceuticals currently has 23.988.000 shares in issue. The market capitalisation of Cipher Pharmaceuticals is $362,70 million. Cipher Pharmaceuticals has a price to earnings ratio (PE ratio) of 17.03.

CPH Neueste Nachrichten

OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX

NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cipher...

Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

MISSISSAUGA, Ontario, June 12, 2019 (GLOBE NEWSWIRE) -- Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company"), in accordance with Toronto Stock Exchange requirements, announced today...

Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical sol...

The agreement will expand the availability of the first and only U.S. FDA-approved prescription product for the treatment of raised seborrheic keratoses (SKs) WAYNE, Pa., April 06, 2018...

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome PR Newswire MISSISSAUGA, ON, and VANCOUVER, March 20, 2018 Cipher to Acquire...

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals PR Newswire MISSISSAUGA, ON, Feb. 28, 2018 A new differentiated treatment...

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III...

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III Study PR Newswire PETACH TIKVA, Israel, May 16, 2017 PETACH TIKVA...

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ PR Newswire MISSISSAUGA, ON, Nov. 29, 2016 MISSISSAUGA, ON, Nov. 29, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc...

Cipher Pharmaceuticals Reports Q3 2016 Financial Results

Cipher Pharmaceuticals Reports Q3 2016 Financial Results PR Newswire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR;...

Cipher Pharmaceuticals Announces Management Change

Cipher Pharmaceuticals Announces Management Change PR Newswire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH...

Cipher Pharmaceuticals Responds to Request for Comment from IIROC

Cipher Pharmaceuticals Responds to Request for Comment from IIROC PR Newswire MISSISSAUGA, ON, Oct. 31, 2016 MISSISSAUGA, ON, Oct. 31, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
12.3319.098360655712.216.2311.5225712415.49879374CS
4-1.68-10.363972856316.2119.6911.5211497916.47002893CS
126.172.36061684468.4319.698.017123414.55679593CS
266.1272.77051129618.4119.697.95103012.34425084CS
5210.05224.3303571434.4819.694.13981810.13484409CS
15612.29548.6607142862.2419.691.55302895.95697176CS
26012.93808.1251.619.690.38368593.54343916CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
VRTSVertiqal Studios Corporation
$ 0,015
(50,00%)
10k
CRWNCrown Capital Partners Inc
$ 1,32
(23,36%)
210
BABYElse Nutrition Holdings Inc
$ 0,035
(16,67%)
126k
WRXWestern Resources Corp
$ 0,07
(16,67%)
1,5k
OGDOrbit Garant Drilling Inc
$ 0,60
(13,21%)
25k
AMMAlmaden Minerals Ltd New
$ 0,065
(-18,75%)
8,81k
CNTCentury Global Commodities Corporation
$ 0,025
(-16,67%)
37,75k
FFFirst Mining Gold Corp
$ 0,135
(-12,90%)
3,27M
LSPKLifeSpeak Inc
$ 0,455
(-10,78%)
3,5k
BYLBaylin Technologies Inc
$ 0,35
(-10,26%)
637
TRPTC Energy Corporation
$ 61,95
(1,51%)
14,19M
CVECenovus Energy Inc
$ 23,15
(-0,86%)
12,24M
ATHAthabasca Oil Corporation
$ 5,23
(-1,51%)
10,1M
LUNLundin Mining Corporation
$ 13,14
(-1,79%)
9,73M
VRNVeren Inc
$ 8,63
(-1,82%)
8,84M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock